Driving community-led demand for DR-TB services

Equitable access to quality DR-TB medicines and care

Affordable medicines for developing countries

Scaling up treatments for HIV, tuberculosis and malaria

Innovative diagnostics for multidrug-resistant tuberculosis

Expanding the market for treating MDR-TB

Expanding diagnosis for MDR-TB